Translationally-focused clinician, with a number of key research themes; spanning early identification of liver disease in the populace, namely Steatotic Liver Disease (SLD) particularly MASLD, including natural history epidemiology, recognition of social and environmental determinants.
His other principle focus is understanding the immunological basis of, and use of novel cellular-based treatments for chronic liver disease.
He is a member of the Global NASH Council (GNC) and Lancet Commission for early detection of liver disease in primary care. He is also a founder member of both a UK-wide hepatology-based trainee network (ToRcH-UK), and a co-applicant on a Scottish-led initiative (SHARP) funded by the National Institute for Health and Research (NIHR) to improve accessibility in liver services.
